While tech leaders like Sam Altman and Dario Amodei claim AI will cure cancer within a decade, medical experts urge caution. Cancer is not a single disease but a highly complex group of over 100 tumor types. Clinicians like Sherene Loi and Felix Sahm emphasize that AI cannot bypass physical experiments or complex biological realities. Furthermore, regulatory hurdles remain high; Emilia Javorsky notes that no AI-designed drug has yet achieved full regulatory approval and clinical adoption.
Tech industry claims on curing disease
- ▪Anthropic CEO Dario Amodei has suggested that AI could cure cancer and many other diseases within a decade.
- ▪OpenAI CEO Sam Altman suggested that curing cancer might be a matter of computing power, writing that AI might figure out a cure with 10 gigawatts of compute.
- ▪Google DeepMind spin-off IsoLabs operates with a mission statement to solve all disease using artificial intelligence.
Ajit Goenka's pancreatic cancer research
- ▪A 2022 proof-of-concept study by Ajit Goenka confirmed that machine-learning tools can detect pancreatic tumors on CT scans before clinical diagnosis, even in pancreases that appeared normal.
- ▪Ajit Goenka, a radiologist at the Mayo Clinic, has been exploring the early detection of pancreatic cancer using machine-learning tools since 2021.
Felix Sahm on brain tumor AI
- ▪Felix Sahm, a neuropathologist at University Hospital Heidelberg, stated that there are more than 100 types of tumors in the human brain, presenting numerous unresolved research and care questions.
- ▪Felix Sahm leads EUcanAI, a European multidisciplinary collaboration using agentic AI to improve treatment efficiency and reduce uncertainty for brain tumor and central nervous system cancer patients.
Emilia Javorsky on AI drug discovery
- ▪Emilia Javorsky, a physician and scientist at the Future of Life Institute, argued that AI drug discovery is limited because biology must be measured rather than computed.
- ▪Emilia Javorsky noted in March 2026 that despite 13 years of the AI drug discovery movement, no AI-designed drug has cleared the full bar of regulatory approval, reimbursement, and clinical adoption.
AI's potential for equitable cancer care
- ▪Cancer experts believe AI will deliver efficiencies in treatment, diagnostics, and pathology services, heralding more personalized and equitable cancer care.
- ▪Medical oncologist Sherene Loi stated that machine-learning models could improve equity of and access to cancer care, particularly for rural communities lacking local specialists.
Story comments
Loading comments…